Financial Times reports Novo Nordisk (NVO.N) does not rule o
文 / 小金
2026-09-23 12:10:03
来源:亚金网
Financial Times reports Novo Nordisk (NVO.N) does not rule out upgrading its New York listing to raise its profile in the U.S. market; the Danish weight‑loss drug maker is exploring the move. AstraZeneca took a similar step earlier this year.
